Androgen Receptor Signalling in Prostate Cancer: The Functional Consequences of Acetylation

The androgen receptor (AR) is a ligand activated transcription factor and member of the steroid hormone receptor (SHR) subfamily of nuclear receptors. In the early stages of prostate carcinogenesis, tumour growth is dependent on androgens, and AR directly mediates these effects by modulating gene expression. During transcriptional regulation, the AR recruits numerous cofactors with acetylation-modifying enzymatic activity, the best studied include p300/CBP and the p160/SRC family of coactivators. It is known that recruitment of histone acetyltransferases (HATs) and histone deacetylases (HDACs) is key in fine-tuning responses to androgens and is thus likely to play a role in prostate cancer progression. Further, these proteins can also modify the AR itself. The functional consequences of AR acetylation, the role of modifying enzymes in relation to AR transcriptional response, and prostate cancer will be discussed.

• Publication year

  2010

• Venue

  Journal of Biomedicine and Biotechnology

• Publication date

  2010-12-28

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1155/2011/862125PMID 21274273PMCID 3022265
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Global cancer statistics

  2011cited by this paper
• HEY1 Leu94Met gene polymorphism dramatically modifies its biological functions

  2010cited by this paper
• Apoptosis by dietary agents for prevention and treatment of prostate cancer.

  2010cited by this paper
• A 629RKLKK633 motif in the hinge region controls the androgen receptor at multiple levels

  2010cited by this paper
• Normal and cancer-related functions of the p160 steroid receptor co-activator (SRC) family

  2009cited by this paper
• Posttranslational modification of p53: cooperative integrators of function.

  2009cited by this paper
• Histone acetyl transferases as emerging drug targets.

  2009cited by this paper
• Steroid receptor phosphorylation: Assigning function to site‐specific phosphorylation

  2009cited by this paper
• The Role of Androgen Receptor Mutations in Prostate Cancer Progression

  2009cited by this paper
• Histone acetyltransferase inhibitors and preclinical studies

  2009cited by this paper
• Posttranscription Regulation of Prostate Cancer Growth

  2008cited by this paper
• Targeting the androgen receptor pathway in prostate cancer.

  2008cited by this paper
• A global view of transcriptional regulation by nuclear receptors: gene expression, factor localization, and DNA sequence analysis

  2008cited by this paper
• Structural basis for the nuclear import of the human androgen receptor

  2008influential reference
• Mutations in the Androgen Receptor Gene Are Associated with Progression of Human Prostate Cancer to Androgen Independence I

  2008cited by this paper
• Genomic Androgen Receptor-Occupied Regions with Different Functions, Defined by Histone Acetylation, Coregulators and Transcriptional Capacity

  2008cited by this paper
• Androgen and estrogen receptors: potential of crystallography in the fight against cancer.

  2007cited by this paper
• The functional significance of nuclear receptor acetylation.

  2007cited by this paper
• Androgen receptor (AR) coregulators: a diversity of functions converging on and regulating the AR transcriptional complex.

  2007influential reference
• Androgen receptor coregulators and their involvement in the development and progression of prostate cancer

  2007cited by this paper
• Histone deacetylase inhibitors sensitize prostate cancer cells to agents that produce DNA double-strand breaks by targeting Ku70 acetylation.

  2007cited by this paper
• The hinge region regulates DNA binding, nuclear translocation, and transactivation of the androgen receptor.

  2007cited by this paper
• Hormonal Control of Androgen Receptor Function through SIRT1

  2006influential reference
• Improving the outcome of patients with castration-resistant prostate cancer through rational drug development

  2006cited by this paper
• Spatial and temporal recruitment of androgen receptor and its coactivators involves chromosomal looping and polymerase tracking.

  2005cited by this paper
• Androgen receptor corepressors: An overview

  2005cited by this paper
• Structure and function of steroid receptor AF1 transactivation domains: induction of active conformations.

  2005cited by this paper
• Chemical ablation of androgen receptor in prostate cancer cells by the histone deacetylase inhibitor LAQ824

  2005cited by this paper
• Global Cancer Statistics, 2002

  2005cited by this paper
• Regulation of androgen receptor and histone deacetylase 1 by Mdm2-mediated ubiquitylation

  2005cited by this paper
• Hey1, a Mediator of Notch Signaling, Is an Androgen Receptor Corepressor

  2005cited by this paper
• Curcumin, a Novel p300/CREB-binding Protein-specific Inhibitor of Acetyltransferase, Represses the Acetylation of Histone/Nonhistone Proteins and Histone Acetyltransferase-dependent Chromatin Transcription*

  2004cited by this paper
• Expression and function of androgen receptor coactivators in prostate cancer.

  2004cited by this paper
• The Hinge Region of the Androgen Receptor Plays a Role in Proteasome‐Mediated Transcriptional Activation

  2004cited by this paper
• The Androgen Receptor Acetylation Site Regulates cAMP and AKT but Not ERK-induced Activity*

  2004cited by this paper
• Acetylation of nuclear receptors in cellular growth and apoptosis.

  2004cited by this paper
• DNA recognition by nuclear receptors.

  2004cited by this paper
• Coregulator recruitment and histone modifications in transcriptional regulation by the androgen receptor.

  2004cited by this paper
• p300/CBP and cancer

  2004cited by this paper
• Acetylation of Androgen Receptor Enhances Coactivator Binding and Promotes Prostate Cancer Cell Growth

  2003influential reference
• Androgen-induced recruitment of RNA polymerase II to a nuclear receptor–p160 coactivator complex

  2003cited by this paper
• Nuclear receptor modifications and endocrine cell proliferation.

  2003cited by this paper
• Involvement of Proteasome in the Dynamic Assembly of the Androgen Receptor Transcription Complex*

  2002cited by this paper
• Formation of the androgen receptor transcription complex.

  2002cited by this paper
• Tip60 and Histone Deacetylase 1 Regulate Androgen Receptor Activity through Changes to the Acetylation Status of the Receptor*

  2002influential reference
• Molecular biology of the androgen receptor.

  2002influential reference
• Tip60 Is a Co-activator Specific for Class I Nuclear Hormone Receptors*

  2001cited by this paper
• The development of androgen-independent prostate cancer

  2001cited by this paper
• CREB-binding Protein and p300 in Transcriptional Regulation*

  2001cited by this paper
• Structural evidence for ligand specificity in the binding domain of the human androgen receptor. Implications for pathogenic gene mutations.

  2000cited by this paper
• p300 and p300/cAMP-response Element-binding Protein-associated Factor Acetylate the Androgen Receptor at Sites Governing Hormone-dependent Transactivation*

  2000cited by this paper
• Mechanisms of androgen receptor activation and function.

  1999cited by this paper
• The AF1 and AF2 Domains of the Androgen Receptor Interact with Distinct Regions of SRC1

  1999cited by this paper
• Tip60 Is a Nuclear Hormone Receptor Coactivator*

  1999cited by this paper
• Nuclear receptor coregulators: cellular and molecular biology.

  1999cited by this paper
• The Steroid Receptor Coactivator-1 Contains Multiple Receptor Interacting and Activation Domains That Cooperatively Enhance the Activation Function 1 (AF1) and AF2 Domains of Steroid Receptors*

  1998cited by this paper
• Distinct steady-state nuclear receptor coregulator complexes exist in vivo.

  1998cited by this paper
• Novel Substrate Specificity of the Histone Acetyltransferase Activity of HIV-1-Tat Interactive Protein Tip60*

  1997cited by this paper
• Steroid receptor coactivator-1 is a histone acetyltransferase

  1997cited by this paper
• Interaction between the Amino- and Carboxyl-terminal Regions of the Rat Androgen Receptor Modulates Transcriptional Activity and Is Influenced by Nuclear Receptor Coactivators*

  1997cited by this paper
• Mutations in the androgen receptor gene are associated with progression of human prostate cancer to androgen independence.

  1996cited by this paper
• CREB binding protein acts synergistically with steroid receptor coactivator-1 to enhance steroid receptor-dependent transcription.

  1996cited by this paper
• The nuclear hormone receptor coactivator SRC-1 is a specific target of p300.

  1996cited by this paper
• The CBP co-activator is a histone acetyltransferase

  1996cited by this paper
• The transcriptional coactivators p300 and CBP are histone acetyltransferases.

  1996cited by this paper
• Identification of Two Transcription Activation Units in the N-terminal Domain of the Human Androgen Receptor (*)

  1995cited by this paper
• Transcriptional activation and nuclear targeting signals of the human androgen receptor.

  1991cited by this paper
• Domains of the human androgen receptor involved in steroid binding, transcriptional activation, and subcellular localization.

  1991cited by this paper
• The endocrinology and developmental biology of the prostate.

  1987cited by this paper

• Epigenetic abnormalities and neuroendocrine differentiation in prostate cancer

  2025cites this paper
• Regulating Androgen Receptor Function in Prostate Cancer: Exploring the Diversity of Post-Translational Modifications

  2024cites this paper
• Overexpression of miR-17-5p may negatively impact p300/CBP factor-associated inflammation in a hypercholesterolemic advanced prostate cancer model

  2023cites this paper
• Epigenetic (De)regulation in Prostate Cancer.

  2023cites this paper
• Epigenetic and Epitranscriptomic Control in Prostate Cancer

  2022cites this paper
• Benefits and pitfalls: Epigenetic modulators in prostate cancer intervention

  2021cites this paper
• Roles of Key Epigenetic Regulators in the Gene Transcription and Progression of Prostate Cancer

  2021cites this paper
• Epigenetic Editing in Prostate Cancer: Challenges and Opportunities

  2021cites this paper
• CBP/p300: Critical Co-Activators for Nuclear Steroid Hormone Receptors and Emerging Therapeutic Targets in Prostate and Breast Cancers

  2021cites this paper
• NAA10 as a New Prognostic Marker for Cancer Progression

  2020influential citation
• Study of the frequencies of rs137852579 in Androgen receptor coding gene in patients suffering from prostate cancer and theoretical study of the association of this polymorphism with drug resistance to treatment with enzalutamide

  2020cites this paper
• The Prospect of Identifying Resistance Mechanisms for Castrate-Resistant Prostate Cancer Using Circulating Tumor Cells: Is Epithelial-to-Mesenchymal Transition a Key Player?

  2020cites this paper
• Epigenetic polypharmacology: A new frontier for epi‐drug discovery

  2020cites this paper
• Diverse roles of arrest defective 1 in cancer development

  2019cites this paper
• Molecular Mechanisms Related to Hormone Inhibition Resistance in Prostate Cancer

  2019cites this paper
• Epigenetic Regulation in Prostate Cancer Progression

  2018cites this paper
• ARD1/NAA10 acetylation in prostate cancer

  2018cites this paper
• Epigenetic Therapy with Panobinostat Combined with Bicalutamide Rechallenge in Castration-Resistant Prostate Cancer

  2018cites this paper
• Reversing resistance to antiandrogens with a histone deacetylase inhibitor

  2018cites this paper
• Combination treatment with docetaxel and histone deacetylase inhibitors downregulates androgen receptor signaling in castration-resistant prostate cancer

  2018cites this paper
• 27-hydroxycholesterol: A novel player in molecular carcinogenesis of breast and prostate cancer.

  2017cites this paper
• Epigenomic Regulation of Androgen Receptor Signaling: Potential Role in Prostate Cancer Therapy

  2017cites this paper
• Exploiting Epigenetic Alterations in Prostate Cancer

  2017cites this paper
• Recent Developments in Androgen Receptor Antagonists

  2015cites this paper
• BCAS2 promotes prostate cancer cells proliferation by enhancing AR mRNA transcription and protein stability

  2014cites this paper
• A Comparative Approach to Assessing the Functional and Structural Characteristics of Human FKBP52 in the Regulation of Steroid Hormone Receptor Signaling Pathway

  2014cites this paper
• Functional characterisation of phosphodiesterase 4D7 in prostate cancer

  2014cites this paper
• Simulasi Docking Senyawa Kurkumin dan Analognya Sebagai Inhibitor Reseptor Androgen pada Kanker Prostat

  2014cites this paper
• Androgen Receptor Promotes the Oncogenic Function of Overexpressed Jagged1 in Prostate Cancer by Enhancing Cyclin B1 Expression via Akt Phosphorylation

  2014cites this paper
• Cell Cycle and Senescence Androgen Receptor Promotes the Oncogenic Function of Overexpressed Jagged 1 in Prostate Cancer by Enhancing Cyclin B 1 Expression via Akt Phosphorylation

  2014cites this paper
• Identification and classification of prostate tumour tissues by FTIR

  2013cites this paper
• Emerging Molecularly Targeted Therapies in Castration Refractory Prostate Cancer

  2013cites this paper
• Posttranslational Modification of the Androgen Receptor in Prostate Cancer

  2013cites this paper
• New therapeutic modalities for castrate resistant prostate cancer at the beginning of 2013

  2013cites this paper
• Regulation of CXCR4 gene expression in breast cancer cells under diverse stress conditions.

  2012cites this paper
• Rhodanine carboxylic acids as novel inhibitors of histone acetyltransferases

  2012cites this paper
• Linking cohesin-dependent transcription with cell pluripotency

  2012cites this paper
• 7-epi-nemorosone from Clusia rosea induces apoptosis, androgen receptor down-regulation and dysregulation of PSA levels in LNCaP prostate carcinoma cells.

  2012cites this paper
• Adenovirus-Mediated Sensitization to the Cytotoxic Drugs Docetaxel and Mitoxantrone Is Dependent on Regulatory Domains in the E1ACR1 Gene-Region

  2012cites this paper
• Gene Regulation by Cohesin in Cancer: Is the Ring an Unexpected Party to Proliferation?

  2011cites this paper
• Expression and responsiveness of cytokines and their receptors in breast cancer

  2011cites this paper
• Profiling post translational modification of histone and p53 in human breast carcinomas

  2011cites this paper
• Influence de l'acide rétinoïque et des stéroïdes sexuels sur l'entrée en méiose des cellules germinales et la prolifération des cellules de tumeurs testiculaires d'origine germinale

  2011cites this paper
• Androgen receptor levels during progression of prostate cancer in the transgenic adenocarcinoma of mouse prostate model

  2010cites this paper